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The Pineal Gland:  
The pineal gland, a pea-sized organ near the centre of the brain, converts serotonin into 
melatonin. This has a strong diurnal (daily) pattern, with high melatonin output at night and low 
melatonin output during the day. Alternatively, serotonin dominates the day and is lower at 
night. The Melatonin/Serotonin cycle is a primary physiological driver of the daily metabolic, 
awake/sleep cycle. Melatonin is a vital part of many of the bodies biochemical systems, 
including sleep and learning and is free radical scavenging in all cells and hence is a potent 
antioxidant with anti-aging and anti-cancer properties. It helps to protect embryonic fetuses. 
Melatonin mediates many hormone functions, assists in maintaining immune system health and 
virus protection.  





Figure 1: A schematic cross-section of the brain highlighting the pineal glad. 
The light-driven daily cycle is primarily controlled by signals from the retina of the eyes that 
mediate the pineal function though a flow of chemical messengers. Signal messengers from the 
retina arrive at the receptors on the surface of the pinealocytes. Through regulation of the cyclic 
AMP (cAMP) pathway, the serotonin/melatonin transformation is controlled.  
A key element of the cAMP pathway is calcium ions. Substances that can alter cellular calcium 
ions act at many levels involving many cell receptors and cellular processes. Calcium ion efflux 
from the pinealocytes has the effect of reducing melatonin through reducing the cAMP, Figure 2.  
   
   
 




Figure 2: The biochemical mediation system for serotonin 
transformation to melatonin in the pinealocytes showing the signal 
transduction pathways from the retina to the cell and the cell 
receptor, through cyclic AMP and NAT to the transformation 
process, Reiter (1994). 
EMR alters calcium ion homeostasis:  
Electromagnetic radiation across the spectrum alters calcium ion homeostasis in cells. The 
primary factor is the ELF modulation of the signal, Bawin and Adey (1976), Adey (1980). This 
occurs in a complex set of exposure windows. The efflux and influx for calcium ions also varies 
with ambient temperature, geomagnetic field strength and orientation, and signal intensity, 
Blackman et al. (1988, 1989, 1991). Blackman (1990) concludes that this is an established 
biological mechanism. Blackman et al. (1991) showed that Ca2+ efflux occurred for tissue 
temperatures of 36 C and 37  C and not at 35 C and 38 C. They comment that these could be 
very good reasons why experimental outcomes have been difficult to confirm in some 
laboratories. This shows why high SAR exposures do not produce altered calcium ions because 
the rise in tissue temperature takes the tissue outside the homeostatic thermal range within which 
calcium ion efflux/influx occurs to regulate normal cell behaviour.  
The calcium ion efflux research demonstrates one of the fundamental principles of EMR 
research. Under given specific conditions the calcium ion efflux (positive or negative) does occur 
at some combination of exposure conditions, but not at a nearby slightly different set of 
conditions. This is because of the "window" non-linear nature of the effect with respect to 
modulation frequency and intensity in particular. Also, one set of conditions that produce a 
significant effect in one laboratory does not produce any observed effect in another laboratory 
because it has a different geomagnetic field. On the other hand, in real world situations workers 
or residents are continually passing through effective and non-effective windows of exposure.  
There are great difficulties of detecting melatonin reduction in people because of the large intra-
personal differences from day to day, and the very large inter-personal differences. Despite this, 
on average there is a dominance of exposure conditions that do cause calcium ion efflux and 
reduced melatonin, so that it is observed to differ in most monitored populations in the real 
world.  
EMR Reduces Melatonin in Animals:  
Light-at-night and electromagnetic radiation, are proven to reduce melatonin and hence pose 
significant adverse health effects. The evidence for EMR is summarized here. Rosen, Barber and 
Lyle (1998) state that seven different laboratories have reported suppression of nighttime rise in 
pineal melatonin production in laboratory animals. They show that a 50  T, 60 Hz field with a 
0.06 T DC field, over 10 experiments, averages a 46% reduction in melatonin production from 
pinealocytes. Yaga et al. (1993) showed that rat pineal response to ELF pulsed magnetic fields 
varied significantly during the light- dark-cycle. They found that the rate-limiting enzyme in 
melatonin synthesis, N-acetyltransferase (NAT) activity showed that magnetic field exposure 
significantly suppressed NAT during the mid- to late dark phase.  




Stark et al. (1997) observed a significant increase in salival melatonin in a group of 5 cows when 
the short-wave radio transmitter at Schwarzenberg, Switzerland, was turned off for three days, 
compared to 5 cows that had much lower RF exposure. Hence there are now at least ten 
independent observations of melatonin reduction in animals from ELF and RF exposure.  
EMR Reduces Melatonin in People:  
Fifteen studies from show that ELF and RF/MW exposure reduces melatonin in people and a 
serotonin enhancement. Evidence that EMR reduced melatonin in human beings commenced 
with Wang (1989) who found that workers who were more highly exposed to RF/MW had a 
dose-response increase in serotonin, and hence indicates a reduction in melatonin. Thirteen 
studies have observed significant EMR associated melatonin reduction in humans.  
They involve a wide range of exposure situations, including 50/60 Hz fields, Wilson et al. 
(1990), Graham et al. (1994), Davis (1997) [in a dose response manner], Wood et al. (1998), 
Karasek et al. (1998), and Burch et al. (1997, 1998, 1999a, 2000), Jutilainen et al. (2000) and 
Graham et al. (2000); 16.7 Hz fields, Pfluger et al. (1996), VDTs Arnetz et al. (1996), a 
combination of 60 Hz fields and cell phone use, Burch et al. (1997), and a combination of 
occupational 60Hz exposure and increased geomagnetic activity around 30nT, Burch et al. 
(1999b).  
The Davis (1997) study involved residential exposures and observed nocturnal reductions in 
melatonin metabolite, 6-OHMS. The author states that while the effect was small it occurred at 
milligauss levels and followed a dose-response trend. The effect was strongest among women 
who were on medication that also reduces melatonin. They showed a significant dose-response 
trend, with a 2- , 3- and 4-fold increase in magnetic field resulting in 8%, 12 % and 15 % 
reductions in melatonin, respectively.  
The fifteenth human melatonin reduction study is from RF exposure as reported during the 
shutting down process of the Schwarzenburg shortwave radio tower, Professor Theo Abelin 
(seminar and pers.comm.). Urinary melatonin levels were monitored prior to and following the 
closing down of the Schwarzenburg short wave radio transmitter. This showed a significant rise 
in melatonin after the signal was turned off.  
Hence it is established from multiple, independent studies, that EMR 
from ELF to RF/MW reduces melatonin in animals and human beings.  
Confirmation of the electromagnetic sensitivity of the human pineal comes from 
therapeutic uses of picoTesla ELF fields in the successful treatment of a range of 
neurological diseases, Sandyk (1993, 1994), Sandyk and Derpapas (1993) and Sandyk 
and Iacono (1993). These studies specifically involve Parkinson's Disease and Multiple 
Sclerosis. The authors identify the magneto-sensitivity of the pineal gland and the role 
of melatonin as the biological mechanism for this therapy.  
The Health Implications of Reduced Melatonin:  




Melatonin has many biological effects. The melatonin receptor regulates several second 
messengers: cAMP, cGMP, diacylglycerol, inositol trisphosphate, arachidonic acid, and 
intracellular Ca 2+ concentration ([Ca2+]j). In many cases, its effect is inhibitory and 
requires previous activation of the cell by a stimulatory agent. Melatonin inhibits cAMP 
accumulation in most of the cells examined, but the indole effects on other messengers 
have been often observed only in one type of the cells or tissue, until now. Melatonin 
also regulates the transcription factors, namely, phosphorylation of cAMP-responsive 
element binding protein and expression of c-Fos. Molecular mechanisms of the 
melatonin effects are not clear but may involve at least two parallel transduction 
pathways, one inhibiting adenylyl cyclase and the other regulating phosphohpide 
metabolism and [Ca 2+]j, Vaneeck (1998).  
Professor Russell Reiter, one of the world's leading medical researchers into the effects 
of melatonin, summarizes melatonin’s roles, Reiter and Robinson (1995), as being:  
  Vital for healthy sleep, including lowering the body temperature, and assisting in 
maintaining health sleep states.  
o Reduces cholesterol, with consequent reductions is risk of atherosclerosis 
and coronary heart disease.  
o Reduces blood pressure and the tendency for blood clots, and hence 
reduces the risk of strokes.  
o Scavenger of free radicals. This, along with the above factors, reduces the 
risk of heart attack, cancer, viral replication. Melatonin plays a vital free 
radical scavenging role in the brain where, because it is high in iron, has a 
high production rate of hydroxyl radicals (OH ). Free radical damage is 
now known to play a formative role in most brain disorders, including 
Alzheimer’ disease, Lou Gehrig’s disease, multiple sclerosis and 
Parkinson’s disease. While the Blood Brain Barrier (BBB) denies access 
to most free radical scavengers, melatonin has free access.  
o Enhances the effectiveness of the immune system. Specifically enhancing 
the T-cells, i.e. the T-helper cells and the T-killer cells. T-helper cells have 
a receptor for melatonin. When melatonin is received a cascade of events 
is set in motion including stimulation of Interleukin-4 (IL-4) which then 
stimulates natural killer cells (NK), B-cells, IgA, phagocytes and T-
Cytotoxic cells. The NK cells specialize in attacking cancer cells and virus 
infected cells.  
 
   
In Professor Reiter’s book, published in 1995, he describes the evidence that 
EMR/EMF does reduce melatonin as a "Smoking Gun" level of proof. That is, 




there is considerable scientific evidence but at that time it wasn’t sufficient for 
scientific proof. By considering more recent information, and the extensive results 
of biometeorological research, and linking the melatonin research to the calcium 
ion research, the level of proof can be seen as causal. The multiple observations 
of melatonin reduction in EMR exposed populations means that EMR exposure 
increases the incidence of all of the conditions identified by Reiter and Robinson 
above, including impaired immune system, diseases from infections and viruses, 
arthritis, diabetes, cancer, reproductive, neurological and cardiac disease and/or 
death. Epidemiological evidence of exposed workers and residential populations 
confirms all of these, except arthritis, have been identified to occur in EMR 
exposed human populations.  
References:  
Adey, W.R., 1980: "Frequency and Power windowing in tissue interactions with 
weak electromagnetic fields". Proc. IEEE, 68:119-125.  
Arnetz, B.B. and Berg, M., 1996: "Melatonin and Andrenocorticotropic Hormone 
levels in video display unit workers during work and leisure. J Occup Med 38(11): 
1108-1110.  
Bawin, S.M. and Adey, W.R., 1976: "Sensitivity of calcium binding in cerebral 
tissue to weak electric fields oscillating at low frequency". Proc. Natl. Acad. Sci. 
USA, 73: 1999-2003.  
Blackman, C.F., Benane, S.G., Elliott, D.J., and Pollock, M.M., 1988: "Influence 
of Electromagnetic Fields on the Efflux of Calcium Ions from Brain Tissue in 
Vitro: A Three-Model Analysis Consistent with the Frequency Response up to 
510 Hz". Bioelectromagnetics, 9:215-227.  
Blackman, C.F., Kinney, L.S., House, D.E., and Joines, W.T., 1989: "Multiple 
power-density windows and their possible origin". Bioelectromagnetics, 10: 115-
128.  
Blackman, C.F., 1990: "ELF effects on calcium homeostasis". In "Extremely low 
frequency electromagnetic fields: The question of cancer", BW Wilson, RG 
Stevens, LE Anderson Eds, Publ. Battelle Press Columbus: 1990; 187-208.  
Blackman, C.F., Benane, S.G., and House, D.E., 1991: "The influence of 
temperature during electric- and magnetic-field induced alteration of calcium-ion 
release from in vitro brain tissue". Bioelectromagnetics, 12: 173-182.  
Burch, J.B., Reif, J.S., Pittrat, C.A., Keefe, T.J. and Yost, M.G., 1997: "Cellular 
telephone use and excretion of a urinary melatonin metabolite". In: Annual review 
of Research in Biological Effects of electric and magnetic fields from the 
generation, delivery and use of electricity, San Diego, CA, Nov. 9-13, P-52.  
Burch, J.B., Reif, J.S., Yost, M.G., Keefe, T.J. and Pittrat, C.A., 1998: "Nocturnal 
excretion of urinary melatonin metabolite among utility workers". Scand J Work 
Environ Health 24(3): 183-189.  




Burch, J.B., Reif, J.S., Yost, M.G., Keefe, T.J. and Pittrat, C.A., 1999a: "Reduced 
excretion of a melatonin metabolite among workers exposed to 60 Hz magnetic 
fields" Am J Epidemiology 150(1): 27-36.  
Burch, J.B., Reif, J.S. and Yost, M.G., 1999b: "Geomagnetic disturbances are 
associated with reduced nocturnal excretion of melatonin metabolite in humans". 
Neurosci Lett 266(3):209-212.  
Burch, J.B., Reif, J.S., Noonan, C.W. and Yost, M.G., 2000: "Melatonin 
metabolite levels in workers exposed to 60-Hz magnetic fields: work in 
substations and with 3-phase conductors". J of Occupational and Environmental 
Medicine, 42(2): 136-142.  
Davis, S., 1997: "Weak residential Magnetic Fields affect Melatonin in Humans", 
Microwave News, Nov/Dec 1997.  
Graham, C., Cook, M.R., Cohen, H.D. and Gerkovich, M.M., 1994: "A dose 
response study of human exposure to 60Hz electric and magnetic fields". 
Bioelectromagnetics 15: 447-463.  
Graham, C., Cook, M.R., Sastre, A., Riffle, D.W. and Gerkovich, M.M., 2000: 
"Multi-night exposure to 60 Hz magnetic fields: effects on melatonin and its 
enzymatic metabolite". J Pineal Res 28(1): 1-8.  
Juutilainen, J., Stevens, R.G., Anderson, L.E., Hansen, N.H., Kilpelainen, M., 
Laitinen, J.T., Sobel, E. and Wilson, B.W., 2000: "Nocturnal 6-hydroxymelatonin 
sulphate excretion in female workers exposed to magnetic fields". J Pineal Res 
28(2): 97-104.  
Karasek, M., Woldanska-Okonska, M., Czernicki, J., Zylinska, K. and 
Swietoslawski, J., 1998: "Chronic exposure to 2.9 mT, 40 Hz magnetic field 
reduces melatonin concentrations in humans". J Pineal Research 25(4): 240-244.  
Pfluger, D.M. and Minder, C.E., 1996: "Effects of 16.7 Hz magnetic fields on 
urinary 6-hydroxymelatonin sulfate excretion of Swiss railway workers". J Pineal 
Research 21(2): 91-100.  
Reiter, R.J., 1994: "Melatonin suppression by static and extremely low frequency 
electromagnetic fields: relationship to the reported increased incidence of 
cancer". Reviews on Environmental Health. 10(3-4): 171-86, 1994.  
Reiter, R.J. and Robinson, J, 1995: "Melatonin: Your body's natural wonder 
drug". Publ. Bantam Books, New York. 
Rosen, L.A., Barber, I. and Lyle D.B., 1998: "A 0.5 G, 60 HZ magnetic field 
suppresses melatonin production in pinealocytes". Bioelectromagnetics 19: 123-
127.  
Sandyk, R. 1993: "Weak magnetic fields antagonize the effects of melatonin on 
blood glucose levels in Parkinson's Disease". Int. J. Neuroscience 68(1-2): 85-
91.  




Sandyk, R. 1994: "Rapid normalization of visual evoked potentials by picoTesla 
range magnetic fields in chronic progressive multiple sclerosis". Int. J. 
Neuroscience 77(304): 243-259.  
Sandyk, R. and Derpapas, K. 1993: "Further observations on the unique efficacy 
of picoTesla range magnetic fields in Parkinson's Disease". Int. J. Neuroscience 
69(1-4): 167-183.  
Sandyk, R. and Iacono, R.P., 1993: "Reversal of visual neglect in Parkinson's 
Disease by treatment with picoTesla range magnetic fields". Int. J. Neuroscience 
73(1-2): 93-107.  
Stark, K.D.C., Krebs, T., Altpeter, E., Manz, B., Griol, C. and Abelin, T., 1997: 
"Absence of chronic effect of exposure to short-wave radio broadcast signal on 
salivary melatonin concentrations in dairy cattle". J Pineal Research 22: 171-176.  
Vaneeck, J., 1998: "Cellular Mechanisms of Melatonin Action". Physiol. Rev. 78: 
687-721.  
Wang, S.G. 1989: "5-HT contents change in peripheral blood of workers exposed 
to microwave and high frequency radiation". Chung Hua Yu Fang I Hsueh Tsa 
Chih 23(4): 207-210.  
Wilson, B.W., Wright, C.W., Morris, J.E., Buschbom, R.L., Brown, D.P., Miller, 
D.L., Sommers-Flannigan, R. and Anderson, L.E., 1990: "Evidence of an effect of 
ELF electromagnetic fields on human pineal gland function". J Pineal Research 
9(4): 259-269.  
Wood, A.W., Armstrong, S.M., Sait, M.L., Devine, L. and Martin, M.J., 1998: 
"Changes in human plasma melatonin profiles in response to 50 Hz magnetic 
field exposure". J Pineal Research 25(2): 116-127.  
Yaga, K, Reiter, R.J., Manchester, L.C., Nieves, H., Sun, J.H. and Chen, L.D., 
1993: "Pineal sensitivity to pulsed magnetic fields changes during the 
photoperiod. Brain Res Bulletin, 30 (1-2): 153-156. 
 
